Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NEUROLOGIX INC/DE | 7,420,063 | reported | 19 Sept 2011 | tx 1+7,420,063 |
| POZEN INC /NC | 2,944,888 | reported | 12 Nov 2015 | tx 3+2,944,888 |
| INSPIRE PHARMACEUTICALS INC | 446,875 | reported | 13 May 2011 | tx 7+1,095,335−1,095,355 |
| Aralez Pharmaceuticals Inc. | 252,316 | reported | 11 May 2017 | tx 6+4,145,177 |
| IMPEL NEUROPHARMA INC | 200,000 | reported | 14 Feb 2023 | tx 6+445,000 |
| Akebia Therapeutics, Inc. | 53,600 | reported | 10 Jun 2025 | tx 16+449,500 |
| TALPHERA, INC. | 25,600 | reported | 23 Oct 2025 | tx 25+439,403−100,000 |
| NEUROCRINE BIOSCIENCES INC | 12,000 | reported | 30 Jun 2006 | tx 1+12,000 |
| AMYLIN PHARMACEUTICALS INC | 0 | reported | 08 Aug 2012 | tx 22+113,000−133,000 |
| SEPRACOR INC /DE/ | 0 | reported | 20 Oct 2009 | tx 11+1,315,000−816,156 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Oct 2025 | GRANT_AWARD | TALPHERA, INC. | 4,267 | 0.00 USD | |
| 23 Oct 2025 | GRANT_AWARD | TALPHERA, INC. | 25,600 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Akebia Therapeutics, Inc. | 35,700 | 0.00 USD | |
| 10 Jun 2025 | GRANT_AWARD | Akebia Therapeutics, Inc. | 53,600 | 0.00 USD | deriv |
| 24 Jun 2024 | GRANT_AWARD | TALPHERA, INC. | 2,174 | 0.00 USD | |
| 24 Jun 2024 | GRANT_AWARD | TALPHERA, INC. | 13,044 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Akebia Therapeutics, Inc. | 30,000 | 0.00 USD | |
| 06 Jun 2024 | GRANT_AWARD | Akebia Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 10 Oct 2023 | GRANT_AWARD | TALPHERA, INC. | 581 | 0.00 USD | |
| 10 Oct 2023 | GRANT_AWARD | TALPHERA, INC. | 3,487 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | Akebia Therapeutics, Inc. | 30,000 | 0.00 USD | |
| 06 Jun 2023 | GRANT_AWARD | Akebia Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 14 Feb 2023 | GRANT_AWARD | IMPEL NEUROPHARMA INC | 200,000 | 0.00 USD | deriv |
| 15 Jul 2022 | GRANT_AWARD | TALPHERA, INC. | 15,500 | 0.00 USD | |
| 15 Jul 2022 | GRANT_AWARD | TALPHERA, INC. | 31,000 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Akebia Therapeutics, Inc. | 13,700 | 0.00 USD | |
| 08 Jun 2022 | GRANT_AWARD | Akebia Therapeutics, Inc. | 20,100 | 0.00 USD | deriv |
| 26 Jan 2022 | GRANT_AWARD | IMPEL NEUROPHARMA INC | 175,000 | 0.00 USD | deriv |
| 18 Aug 2021 | PURCHASE | IMPEL NEUROPHARMA INC | 17,203 | 13.81 USD | |
| 18 Aug 2021 | PURCHASE | IMPEL NEUROPHARMA INC | 2,197 | 14.91 USD | |
| 18 Aug 2021 | PURCHASE | IMPEL NEUROPHARMA INC | 600 | 15.89 USD | first after silence |
| 20 Jul 2021 | GRANT_AWARD | IMPEL NEUROPHARMA INC | 50,000 | 0.00 USD | deriv |
| 17 Jun 2021 | GRANT_AWARD | TALPHERA, INC. | 10,000 | 0.00 USD | |
| 17 Jun 2021 | GRANT_AWARD | TALPHERA, INC. | 20,000 | 0.00 USD | deriv |
| 02 Jun 2021 | GRANT_AWARD | Akebia Therapeutics, Inc. | 13,700 | 0.00 USD |
6 purchases reported after at least 12 months of silence — most recent on 18 Aug 2021.